Table of Contents

company-logo

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in Phase I clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense. PCI Biotech Holding ASA is based in Oslo, Norway.

PCI Biotech Dividend Announcement

• PCI Biotech does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on PCI Biotech dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

PCI Biotech Dividend History

PCI Biotech Dividend Yield

PCI Biotech current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing PCI Biotech stock? Use our calculator to estimate your expected dividend yield:

PCI Biotech Financial Ratios

P/E ratio-3.31
PEG ratio0.65
P/B ratio1.65
ROE-44.86%
Payout ratio0.00%
Current ratio6.86
Quick ratio6.86
Cash Ratio5.67

PCI Biotech Dividend FAQ

Does PCI Biotech stock pay dividends?
PCI Biotech does not currently pay dividends to its shareholders.
Has PCI Biotech ever paid a dividend?
No, PCI Biotech has no a history of paying dividends to its shareholders. PCI Biotech is not known for its dividend payments.
Why doesn't PCI Biotech pay dividends?
There are several potential reasons why PCI Biotech would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will PCI Biotech ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While PCI Biotech has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is PCI Biotech a dividend aristocrat?
PCI Biotech is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is PCI Biotech a dividend king?
PCI Biotech is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is PCI Biotech a dividend stock?
No, PCI Biotech is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy PCI Biotech stocks?
To buy PCI Biotech you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy PCI Biotech stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.